Spruce Biosciences, Inc.SPRB
Price (close)
$49.02
Market cap
$134.9M
P/E
—
Revenue (TTM)
$0
Net income
-$51.4M
Dividend yield
—
1-year total return
532.5%
Net margin
—
Revenue growth
—
Debt / equity
0.08x
What Spruce Biosciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $10.1M | $4.9M | $0 |
| Net income | -$29.5M | -$42.3M | -$46.2M | -$47.9M | -$53.0M | -$39.0M |
| Free cash flow | -$27.6M | -$36.0M | -$41.7M | -$33.3M | -$56.0M | — |
More on SPRB.
- Spruce Biosciences, Inc. summary
- Spruce Biosciences, Inc. financial statements
- Spruce Biosciences, Inc. key metrics
- Spruce Biosciences, Inc. health scores and style box
- Spruce Biosciences, Inc. earnings
- Spruce Biosciences, Inc. dividends
- Spruce Biosciences, Inc. valuation
- Spruce Biosciences, Inc. ownership and insiders
- Spruce Biosciences, Inc. peers
Figures from Spruce Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.